Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

MRKR holding history

Marker Therapeutics, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRKR overviewAll 13F holders of MRKRFull Q2 2026 holdings

Shares (Q2 2026)
17,312
Value
$25.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MRKR by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,312$25.4K<0.1%00.0%UnchangedHolders
Q1 202617,312$22.5K<0.1%00.0%UnchangedHolders
Q4 202517,312$25.8K<0.1%00.0%UnchangedHolders
Q3 202517,312$15.5K<0.1%00.0%UnchangedHolders
Q2 202517,312$26.5K<0.1%00.0%UnchangedHolders
Q1 202517,312$21.3K<0.1%00.0%UnchangedHolders
Q4 202417,312$53.8K<0.1%00.0%UnchangedHolders
Q3 202417,312$48.8K<0.1%00.0%UnchangedHolders
Q2 202417,312$94.0K<0.1%00.0%UnchangedHolders
Q1 202417,312$74.4K<0.1%00.0%UnchangedHolders
Q4 202317,312$95.2K<0.1%00.0%UnchangedHolders
Q3 202317,312$78.6K<0.1%00.0%UnchangedHolders
Q2 202317,312$53.7K<0.1%−250−1.4%ReducedHolders
Q1 202317,562$12.5K<0.1%−602−3.3%ReducedConverted for a 1-for-10 splitHolders
Q4 2022181,641$48.3K<0.1%00.0%UnchangedHolders
Q3 2022181,641$67.0K<0.1%00.0%UnchangedHolders
Q2 2022181,641$60.0K<0.1%+6,600+3.8%AddedHolders
Q1 2022175,041$77.0K<0.1%00.0%UnchangedHolders
Q4 2021175,041$166.0K<0.1%+29,680+20.4%AddedHolders
Q3 2021145,361$246.0K<0.1%−5,000−3.3%ReducedHolders
Q2 2021150,361$420.0K<0.1%−11,000−6.8%ReducedHolders
Q1 2021161,361$361.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.